Previous study has shown that HDAC inhibitors increased the histone acetylation levels of the leukemia inhibitory factor receptor (LIFR) gene promoter region, recruiting the histone acetylation recognition protein-bromodomain-containing protein 4 (BRD4), which subsequently upregulated LIFR expression in tumor tissues. Here, LIFR is linked to neoplasm.